1-16 of 16
prognostic marker
Close
Sort by
Journal Articles

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

Gianluca Gaidano, Davide Rossi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 329–337.
https://doi.org/10.1182/asheducation-2017.1.329
Published: 2017
Journal Articles

How should we sequence and combine novel therapies in CLL?

Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 346–353.
https://doi.org/10.1182/asheducation-2017.1.346
Published: 2017
Journal Articles

Prognostic factors in follicular lymphoma: new tools to personalize risk

Carla Casulo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 269–276.
https://doi.org/10.1182/asheducation-2016.1.269
Published: 2016
Journal Articles

First-line therapy for young patients with CLL

Nitin Jain, Susan O’Brien
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 146–148.
https://doi.org/10.1182/asheducation-2016.1.146
Published: 2016
Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.
https://doi.org/10.1182/asheducation-2015.1.368
Published: 2015
Journal Articles

Implications of new prognostic markers in chronic lymphocytic leukemia

Nicholas Chiorazzi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 76–87.
https://doi.org/10.1182/asheducation.V2012.1.76.3806845
Published: 2012
Journal Articles

Prognostic Markers and Stratification of Chronic Lymphocytic Leukemia

Richard R. Furman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 77–81.
https://doi.org/10.1182/asheducation-2010.1.77
Published: 2010
Journal Articles

Upcoming Diagnostic and Therapeutic Developments in Classical Hodgkin's Lymphoma

Kristie A. Blum
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 93–100.
https://doi.org/10.1182/asheducation-2010.1.93
Published: 2010
Journal Articles

New Prognostic Markers in Acute Myeloid Leukemia: Perspective from the Clinic

James M. Foran
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 47–55.
https://doi.org/10.1182/asheducation-2010.1.47
Published: 2010
Journal Articles

The Present: Optimizing Therapy—Too Much or Too Little?

Nancy L. Bartlett
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 108–114.
https://doi.org/10.1182/asheducation-2010.1.108
Published: 2010
Journal Articles

State-of-the-art treatment of chronic lymphocytic leukemia

Michael Hallek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 440–449.
https://doi.org/10.1182/asheducation-2009.1.440
Published: 2009
Journal Articles

Predicting clinical outcome in CLL: how and why

Tait D. Shanafelt
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 421–429.
https://doi.org/10.1182/asheducation-2009.1.421
Published: 2009
Journal Articles

Disease-Specific Complications of Chronic Lymphocytic Leukemia

Claire Dearden
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 450–456.
https://doi.org/10.1182/asheducation-2008.1.450
Published: 2008
Journal Articles

Familial CLL: Genes and Environment

Lynn R. Goldin, Susan L. Slager
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 339–345.
https://doi.org/10.1182/asheducation-2007.1.339
Published: 2007
Journal Articles

New Prognostic Markers in CLL

Emili Montserrat
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 279–284.
https://doi.org/10.1182/asheducation-2006.1.279
Published: 2006
Journal Articles

Optimal Use of Prognostic Factors in Non-Hodgkin Lymphoma

Laurie H. Sehn
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 295–302.
https://doi.org/10.1182/asheducation-2006.1.295
Published: 2006